People: CVS Caremark Corp (CVS.N)
CVS.N on New York Stock Exchange
61.71USD
10:56am EDT
61.71USD
10:56am EDT
Price Change (% chg)
$-0.46 (-0.74%)
$-0.46 (-0.74%)
Prev Close
$62.17
$62.17
Open
$61.96
$61.96
Day's High
$61.96
$61.96
Day's Low
$61.60
$61.60
Volume
205,939
205,939
Avg. Vol
1,314,507
1,314,507
52-wk High
$62.22
$62.22
52-wk Low
$43.65
$43.65
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
David Dorman |
59 | 2011 | Independent Chairman of the Board |
Larry Merlo |
57 | 2011 | President, Chief Executive Officer, Director |
David Denton |
47 | 2013 | Chief Financial Officer, Executive Vice President |
Lisa Bisaccia |
56 | 2010 | Chief Human Resource Officer, Senior Vice President |
Helena Foulkes |
48 | 2011 | Chief Health Care Strategy and Marketing Officer, Executive Vice President |
Thomas Moriarty |
49 | 2012 | Executive Vice President, General Counsel |
Troyen Brennan |
58 | 2008 | Executive Vice President, Chief Medical Officer |
Mark Cosby |
54 | 2011 | Executive Vice President; President of CVS/pharmacy Inc. |
J. David Joyner |
48 | 2011 | Executive Vice President |
Per Lofberg |
65 | 2012 | Executive Vice President |
Jonathan Roberts |
57 | 2012 | Executive Vice President; President of CVS Caremark Pharmacy Services |
Eva Boratto |
46 | 2013 | Senior Vice President, Chief Accounting Officer, Controller |
Stephen Gold |
53 | 2012 | Senior Vice President, Chief Information Officer |
Laird Daniels |
44 | 2013 | Senior Vice President - International Operations and Business Development |
Andrew Sussman |
47 | 2011 | Senior Vice President, Associate Chief Medical Officer |
C. David Brown |
61 | 2007 | Independent Director |
Anne Finucane |
60 | 2011 | Independent Director |
Kristen Gibney Williams |
64 | 2007 | Independent Director |
Jean-Pierre Millon |
62 | 2007 | Independent Director |
Richard Swift |
68 | 2006 | Independent Director |
William Weldon |
64 | 2013 | Independent Director |
Tony White |
66 | 2011 | Independent Director |
Biographies
| Name | Description |
|---|---|
David Dorman |
Mr. David W. Dorman is Independent Chairman of the Board of CVS Caremark Corp. He has also served as Lead Director of Motorola Solutions, Inc. (formerly Motorola, Inc.), a communications products company, since May 2011, and was Non-Executive Chairman of the Board of Motorola from May 2008 through May 2011. From October 2006 through April 2008, he was a Managing Director and Senior Advisor with Warburg Pincus LLC, a global private equity firm. From November 2005 until January 2006, Mr. Dorman served as President and a director of AT&T Inc., a telecommunications company (formerly known as SBC Communications). Mr. Dorman is also a director of Yum! Brands, Inc., a quick service restaurant company. |
Larry Merlo |
Mr. Larry J. Merlo is President, Chief Executive Officer, Director of CVS Caremark Corp. Mr. Merlo has been the Chief Executive Officer of the company since March 2011 and President since May 2010. Mr. Merlo formerly served as Chief Operating Officer of CVS Caremark Corporation from May 2010 through March 2011 and was President of CVS/pharmacy from January 2007 through January 2010; Executive Vice President of CVS Caremark Corporation from January 2007 to May 2010; Executive Vice President – Stores of CVS Corporation from April 2000 to January 2007; and Executive Vice President – Stores of CVS Pharmacy, Inc. from March 1998 to January 2007. Mr. Merlo has been with CVS and its subsidiaries for more than 30 years. |
David Denton |
Mr. David M. Denton is Chief Financial Officer, Executive Vice President of CVS Caremark Corp. He served as Chief Accounting Officer, Controller of the Company from May 1, 2013 to July 10, 2013. He has been Chief Financial Officer, Executive Vice President of the Company since January 1, 2010. He previously Senior Vice President and Controller/Chief Accounting Officer of CVS Caremark Corporation from March 2008 until December 2009; Senior Vice President, Financial Administration of CVS Caremark Corporation and CVS Pharmacy, Inc. from April 2007 to March 2008. |
Lisa Bisaccia |
Mrs. Lisa G. Bisaccia is Chief Human Resource Officer, Senior Vice President of CVS Caremark Corp. She served as Vice President of Human Resources. Since joining CVS Caremark Corporation in 2004, Mrs. Bisaccia has led human resources initiatives including enhancing compensation practices, outsourcing human resources processing functions, and managing all human resources support for the Retail business. |
Helena Foulkes |
Ms. Helena B. Foulkes is Chief Health Care Strategy and Marketing Officer, Executive Vice President of CVS Caremark Corp. She served as the Executive Vice President and Chief Marketing Officer of CVS Caremark Corporation from January 2009 through February 2011; Senior Vice President of Health Services of CVS Caremark Corporation from May 2008 through January 2009, and of CVS Pharmacy, Inc. from October 2007 through January 2009. |
Thomas Moriarty |
Mr. Thomas M. Moriarty is Executive Vice President, General Counsel of CVS Caremark Corp. He serves as the General Counsel of Celgene Corporation, a global biopharmaceutical company, from May 2012 through September 2012; General Counsel and Corporate Secretary of Medco Health Solutions, Inc., (“Medco”), a pharmacy benefit management company, from March 2008 through April 2012; also President of Global Pharmaceutical Strategies of Medco from March 2011 through April 2012; Senior Vice President, Pharmaceutical Strategies and Solutions of Medco from September 2007 through March 2011; and Senior Vice President, Business Development of Medco from August 2006 through March 2008. |
Troyen Brennan |
Dr. Troyen A. Brennan is Executive Vice President, Chief Medical Officer of CVS Caremark Corp. He serves as the Executive Vice President and Chief Medical Officer of Aetna, Inc. from February 2006 through November 2008; President and Chief Executive Officer of Brigham and Women’s Physician Hospital Organization from 1997 through February 2006; also President and Chief Executive Officer of Brigham and Women’s Physicians Organization from 2000 through February 2006. |
Mark Cosby |
Mr. Mark S. Cosby is Executive Vice President of CVS Caremark Corporation and President of CVS/pharmacy Inc., a subsidiary of the Company. He has responsibility for all aspects of the company’s Retail business including its retail stores, distribution centers and e-commerce site, CVS.com, as well as merchandising, supply chain, marketing, real estate, front store and pharmacy operations. Previously, he served as Macy’s president of stores where he was responsible for all store operations and support functions nationwide. Prior to that he president of full-line stores for Sears Roebuck & Co., chief operations officer of KFC, and chief development officer of Yum! Brands. He serves as the President of Stores of Macy’s, Inc., a retail chain, from April 2009 through August 2011; President of Macy’s East from April 2007 through March 2009; Executive Vice President of Real Estate and Development of Macy’s from July 2006 through March 2007. |
J. David Joyner |
Mr. J. David Joyner is Executive Vice President of CVS Caremark Corporation. He has been Executive Vice President of Sales and Services, CVS Caremark Pharmacy Services since March of 2004. He is responsible for overseeing all new and existing client relationships for CVS Caremark Corporation’s pharmacy benefit management business. Previously, from February 1999 until February 2004, Mr. Joyner served as Senior Vice President of Sales and Marketing for Caremark. Mr. Joyner earned a bachelor's degree in business administration, majoring in finance, from Texas Tech University in Lubbock, Texas and holds a certified employee benefit specialist (CEBS) designation |
Per Lofberg |
Mr. Per G. H. Lofberg is Executive Vice President of CVS Caremark Corp. He served as the Executive Vice President of CVS Caremark Corporation and President of Caremark Pharmacy Services from January 2010 through August 2012; President and Chief Executive Officer of Generation Health, Inc., a pharmacogenomics company, from November 2008 through December 2009; President and Chief Executive Officer of Merck Capital Ventures, LLC, a venture capital investment company focused on the pharmaceutical industry, from January 2001 through July 2008. |
Jonathan Roberts |
Mr. Jonathan C. Roberts is Executive Vice President of CVS Caremark Corp., and the President of CVS Caremark Pharmacy Services of CVS Caremark Corporation. He served as the Executive Vice President of CVS Caremark Corporation and Chief Operating Officer of Caremark Pharmacy Services from October 2010 through August 2011; Executive Vice President, Rx Purchasing, Pricing and Network Relations of CVS Caremark Corporation from January 2009 through October 2010; Senior Vice President and Chief Information Officer of CVS Caremark Corporation from May 2008 until January 2009, and of CVS Pharmacy, Inc. from January 2006 until January 2009. |
Eva Boratto |
Ms. Eva C. Boratto has been appointed as Senior Vice President, Chief Accounting Officer, Controller of CVS Caremark Corporation effective July 10, 2013. Ms. Boratto has served as CVS Caremark’s Senior Vice President – PBM Finance since July 2010. Previously, she served in a number of executive positions during nearly 20 years at Merck & Co., Inc., an international pharmaceutical company, most recently as Vice President – U.S. Market Finance Leader from June 2009 to July 2010 and Vice President – Investor Relations from April 2008 to June 2009. Ms. Boratto holds a B.S. in Accounting and Economics from Rutgers University, Douglass College & School of Business, and an M.B.A. from Drexel University. |
Stephen Gold |
Mr. Stephen J. Gold is Senior Vice President, Chief Information Officer of CVS Caremark Corp. He is Senior Vice President and Chief Information Officer of Avaya, Inc. from May 2010 through June 2012; Executive Vice President, Chief Information Officer and Chief Technology Officer of GSI Commerce, Inc. from February 2005 through April 2010. |
Laird Daniels |
Mr. Laird K. Daniels has been appointed as Senior Vice President - International Operations and Business Development of CVS Caremark Corp., effective May 1, 2013. He served as Senior Vice President, Chief Accounting Officer, Controller of the Company. Previously, Mr. Daniels was Vice President of Finance and Retail Controller of CVS Pharmacy, Inc. from May 2009 through Dece mber 2009; Vice President of Finance-Corporate Budgeting and Analysis of CVS Pharmacy, Inc. from November 2006 until April 2009. |
Andrew Sussman |
Dr. Andrew J. Sussman is Senior Vice President, Associate Chief Medical Officer of CVS Caremark Corporation. He served as President of MinuteClinic, L.L.C., the Company’s retail-based health clinic subsidiary, since September 2009. Previously, from May 2004 through August 2009, Dr. Sussman served as Executive Vice President and Chief Operating Officer of UMass Memorial Medical Center, the teaching affiliate of UMass Medical School, and also served as an Associate Professor of Medicine at the University of Massachusetts Medical School. Before joining UMass Memorial in May 2004, Dr. Sussman served as Chief Medical Officer of the Brigham and Women’s Physicians Organization. At Brigham and Women’s Hospital he practiced primary care internal medicine and taught as an assistant professor of medicine at Harvard Medical School. |
C. David Brown |
Mr. C. David Brown II is Independent Director of CVS Caremark Corp. From 1989 until March 2000, he was Managing Partner of the Orlando office of the firm. He is also a director of Rayonier, Inc., a real estate development, timberland management and cellulose production company. Mr. Brown previously served on the board of Caremark Rx, Inc. from March 2001 until the closing of the CVS/Caremark merger, when he became a director of CVS Caremark. |
Anne Finucane |
Ms. Anne M. Finucane is Independent Director of Cvs Caremark Corp. Ms. Finucane has been the Global Strategy and Marketing Officer for Bank of America Corporation (“BOA”), an international financial services company, since 2006 and has been Northeast Market President for BOA since 2004. During her fifteen-plus years as a senior leader at BOA and its legacy firms, Ms. Finucane has served as senior advisor to four chief executive officers and the Board of Directors, with a focus on corporate strategy and public policy creation and implementation. |
Kristen Gibney Williams |
Ms. Kristen Gibney Williams is Independent Director of CVS Caremark Corp. Ms. Gibney Williams is a former executive of the Prescription Benefits Management Division of Caremark International Inc. and its predecessors, including service as General Manager and as President from 1986 until June 1993 and as Corporate Vice President from June 1993 until her retirement in January 1997. Ms. Gibney Williams previously served on the board of Caremark Rx, Inc. from February 1999 until the closing of the CVS/Caremark merger, when she became a director of CVS Caremark. |
Jean-Pierre Millon |
Mr. Jean-Pierre Millon is Independent Director of CVS Caremark Corp. Mr. Millon is the retired former President and Chief Executive Officer of PCS Health Systems, Inc. (“PCS”). Mr. Millon joined PCS in 1995, where he served as President and Chief Executive Officer from June 1996 until his retirement in September 2000. He has also served as a director of InfuSystems Holdings, Inc., a provider of pumps, supplies and support to oncology practices and clinics, until his resignation from that board in April 2012, and served as a director of Cypress Bioscience, Inc., a biotechnology company, until his resignation from that board in August 2010. Mr. Millon previously served on the board of Caremark Rx, Inc. from March 2004, upon Caremark’s acquisition of AdvancePCS, and as a director of AdvancePCS (which resulted from the merger of PCS and Advance Paradigm, Inc.) beginning in October 2000. He became a director of CVS Caremark upon the closing of the CVS/Caremark merger. |
Richard Swift |
Mr. Richard J. Swift is Independent Director of CVS Caremark Corp. Mr. Swift is the former Chairman of the Board, President and Chief Executive Officer of Foster Wheeler Ltd., an international engineering and construction firm, having served in those positions from April 1994 until his retirement in October 2001. Mr. Swift also served as a member and as Chairman of the Financial Accounting Standards Advisory Council (“FASAC”) from 2002 until his retirement from FASAC in December 2006. Mr. Swift is also a director of Public Service Enterprise Group Incorporated, an energy company, Ingersoll-Rand plc, a diversified industrial company, Kaman Corporation, a diversified manufacturer and distributor, and Hubbell Incorporated, an electrical and electronic products company. |
William Weldon |
Mr. William C. Weldon has been appointed as Independent Director of CVS Caremark Corp., effective March 29, 2013. Mr. Weldon is the former Chairman of the Board and Chief Executive Officer of Johnson & Johnson, a global developer and manufacturer of health care products, having served in those positions from 2002 until his retirement as Chief Executive Officer in April 2012 and his retirement from the board in December 2012. Mr. Weldon previously served in a variety of senior executive positions during his 41-year career with Johnson & Johnson. He is also a director of JPMorgan Chase & Co., a global financial services company. |
Tony White |
Mr. Tony Lee White is Independent Director of Cvs Caremark Corp. Mr. White is the former Chairman of the Board, President and Chief Executive Officer of Applied Biosystems, Inc. (formerly Applera Corporation), a developer, manufacturer and marketer of life science systems and genomic information products, having served in those positions from September 1995 until his retirement in November 2008. Mr. White is also a director of Ingersoll-Rand plc, a diversified industrial company, and C.R. Bard, Inc., a company that designs, manufacturers, packages, distributes and sells medical, surgical, diagnostic and patient care devices. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
David Dorman |
-- |
Larry Merlo |
20,330,100 |
David Denton |
6,062,080 |
Lisa Bisaccia |
-- |
Helena Foulkes |
-- |
Thomas Moriarty |
-- |
Troyen Brennan |
2,918,980 |
Mark Cosby |
5,887,470 |
J. David Joyner |
-- |
Per Lofberg |
7,890,210 |
Jonathan Roberts |
7,863,420 |
Eva Boratto |
-- |
Stephen Gold |
-- |
Laird Daniels |
-- |
Andrew Sussman |
-- |
C. David Brown |
-- |
Anne Finucane |
-- |
Kristen Gibney Williams |
-- |
Jean-Pierre Millon |
-- |
Richard Swift |
-- |
William Weldon |
-- |
Tony White |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
David Dorman |
0 | 0 |
Larry Merlo |
1,472,363 | 14,899,910 |
David Denton |
11,526 | 195,539 |
Lisa Bisaccia |
0 | 0 |
Helena Foulkes |
0 | 0 |
Thomas Moriarty |
0 | 0 |
Troyen Brennan |
0 | 0 |
Mark Cosby |
0 | 0 |
J. David Joyner |
0 | 0 |
Per Lofberg |
0 | 0 |
Jonathan Roberts |
64,546 | 1,001,430 |
Eva Boratto |
0 | 0 |
Stephen Gold |
0 | 0 |
Laird Daniels |
0 | 0 |
Andrew Sussman |
0 | 0 |
C. David Brown |
0 | 0 |
Anne Finucane |
0 | 0 |
Kristen Gibney Williams |
0 | 0 |
Jean-Pierre Millon |
0 | 0 |
Richard Swift |
0 | 0 |
William Weldon |
0 | 0 |
Tony White |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
MILLON JEAN PIERRE |
1,695 | $57.49 |
DORMAN DAVID W |
4,000 | $57.49 |
FINUCANE ANNE M |
1,695 | $57.49 |
WHITE TONY LEE |
1,695 | $57.49 |
WILLIAMS KRISTEN E GIBNEY |
1,695 | $57.49 |
BRENNAN TROYEN A |
34,423 | $36.23 |
BRENNAN TROYEN A |
70,773 | $28.26 |
BRENNAN TROYEN A |
34,422 | $57.34 |
BRENNAN TROYEN A |
34,423 | $57.22 |
FINUCANE ANNE M |
500 | $57.24 |
BRENNAN TROYEN A |
34,422 | $36.23 |
BRENNAN TROYEN A |
70,773 | $57.34 |
ROBERTS JONATHAN C |
16,047 | $54.53 |
SUSSMAN ANDREW J |
5,502 | $54.53 |
BRENNAN TROYEN A |
2,233 | $54.53 |
DANIELS LAIRD |
4,585 | $54.53 |
COSBY MARK S |
13,754 | $54.53 |
JOYNER JOHN DAVID |
2,342 | $54.53 |
MERLO LARRY J |
73,355 | $54.53 |
MORIARTY THOMAS M |
11,462 | $54.53 |
DENTON DAVID M |
2,067 | $54.53 |
BRENNAN TROYEN A |
11,004 | $54.53 |
FOULKES HELENA |
1,157 | $54.53 |
DANIELS LAIRD |
445 | $54.53 |
GOLDING DAVID W |
5,961 | $54.53 |

